Celgene Corp (NASDAQ:CELG)

Add to Watch List

Set Alert

113.38 Real-Time Quote	+1.18 / +1.05% Today’s Change	58.53 Today\|\|\|52-Week Range 131.82	+44.49% Year-to-Date

113.38

Real-Time Quote

+1.18 / +1.05%

Today’s Change

58.53

Today|||52-Week Range

131.82

+44.49%

Year-to-Date

SECTOR

Health Technology

INDUSTRY

Biotechnology

MARKET CAP

$46.8B

Company Description

Celgene Corp. engages in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. It is dedicated to innovative research and development, which is designed to bring new therapies to market and is involved in research in several scientific areas such as immunomodulation and intracellular signaling pathways in hematology, oncology and immune-inflammatory diseases. The company's commercial stage products include Revlimid, Vidaza, Thalomid Abraxane and Istodax. Celgene was founded in 1986 and is headquartered in Summit, NJ.

Contact Information

Celgene Corp.

86 Morris Avenue

Summit New Jersey 07901

P:(908) 673-9000

Investor Relations:
(908) 673-9956

www.celgene.com

Employees

Shareholders

Mutual fund holders	45.49%
Other institutional	39.76%
Individual stakeholders	1.07%

Top Executives

Robert J. Hugin, MBA	Chairman & Chief Executive Officer
Perry A. Karsen	Chief Operating Officer & Executive Vice President
Jacqualyn A. Fouse, PhD	Chief Financial Officer & Executive Vice President
Thomas O. Daniel, MD	EVP, President-Research & Early Development
Jerome Bernard Zeldis, MD, PhD	Chief Medical Officer & CEO-Global Health

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.